\"

Main Conference Day One

9:00 AM - 9:45 AM KEYNOTE –How Technology and Vendor Partnership has Transformed Early Drug Development, and How it Can Further Drive Pharma

9:45 AM - 10:30 AM PANEL DISCUSSION: Benchmarking Compound Capabilities from a Big and Small Pharma Perspective

Matthew Boeckeler, Associate Director: Compound Management Group , AstraZeneca Bill Janzen, Executive Director, Lead Discovery, Epizyme

img

Matthew Boeckeler

Associate Director: Compound Management Group
AstraZeneca
img

Bill Janzen

Executive Director, Lead Discovery
Epizyme

11:15 AM - 12:00 PM Breathing Life into Dark Chemical Matter: Identifying Precious Compounds During Collection Screenings

Anne Wasserman, Associate Principal Scientist, Merck

img

Anne Wasserman

Associate Principal Scientist
Merck

12:00 PM - 12:45 PM Addressing Risk-Based Clinical Sample Management Storage, Logistics, and Partnerships

Oleg Kornienko, Associate Director, External Services Quality Assurance, Novartis

img

Oleg Kornienko

Associate Director, External Services Quality Assurance
Novartis

1:45 PM - 2:30 PM Standardizing Shipping and Handling Logistics to Manage Sample Supply and Demand and Avoid Shipping Nightmares

2:30 PM - 3:15 PM VENDOR SHOWCASE

For thirteen years, we have been bringing together the most innovative pharma discovery champions.

This time, we’re rounding up our tailored team of solution providers to showcase their products to the delegation--- YOU!

Sit back and enjoy learning about the quick specifications of both new-comers and bellwethers in the industry prior to our afternoon DEMO DRIVE!


4:00 PM - 4:45 PM Optimize Internal and External Competencies toward Higher Volume Discoveries Regardless of Your Resources

, ,

4:45 PM - 5:30 PM Implementing New Technology to Optimize Compound Flow from Request to Assay

Marybeth Burton, Director, Discovery Sample Management, Merck

img

Marybeth Burton

Director, Discovery Sample Management
Merck